CRISPR

$78.38

+$1.15 (+1.48%) Today

-$0.23 (-0.29%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

473

Employees473

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

473

Employees473

CRSP Key Statistics

Market cap

6.09B

Market cap6.09B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.31M

Average volume1.31M

High today

$80.10

High today$80.10

Low today

$76.39

Low today$76.39

Open price

$77.54

Open price$77.54

Volume

902.75K

Volume902.75K

52 Week high

$135.70

52 Week high$135.70

52 Week low

$42.51

52 Week low$42.51

CRSP News

Benzinga 5d

Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US - Yahoo Finance

Barclays says that CRISPR Therapeutics AG's (NASDAQ: CRSP) Q2 FY22 earnings release was largely incremental, highlighting the progress of multiple clinical prog...

Analyst ratings

63%

of 27 ratings

Buy

63%

Hold

33.3%

Sell

3.7%

CRSP Earnings

-$2.40

$1.55

$5.49

$9.44

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

-$2.23 per share

Estimated-$2.23 per share

Actual

-$2.40 per share

Actual-$2.40 per share